Boston researchers discover differences in colon cancer tumor cells in younger patients
Key Points:
- Colorectal cancer rates are rising nearly 3% annually among adults under 50, making it the leading cause of cancer-related death in this age group, according to the American Cancer Society.
- Researchers from Mass General Brigham, Dana-Farber Cancer Institute, and the Broad Institute studied 189 tumors and over 850,000 cell nuclei, finding that tumors in younger patients have a higher proportion of stromal cells, which may suppress the immune system and block drug delivery.
- The study also identified genetic differences linked to more aggressive cancer forms in younger patients, offering new directions for research and potential development of treatments tailored to younger individuals.
- Survivor Kristen Vincent, diagnosed at age 37 with stage 3 colorectal cancer, emphasizes the importance of early detection and urges younger adults to seek medical advice if they notice symptoms like blood in stool.
- While the research does not yet explain why colorectal cancer incidence is increasing in younger adults, it provides hope for improved understanding and interventions in the future.